Xuefeng Xia

机构：Nanjing University of Chinese Medicine · ORCID：0000-0001-8712-4724

发表论文 105 篇 · 总被引 2279 次 · h-index 26

代表论文

• Lysine-Tethered Stable Bicyclic Cationic Antimicrobial Peptide Combats Bacterial Infection in Vivo (2022 · Journal of Medicinal Chemistry · 被引 28)
• PASylation improves pharmacokinetic of liposomes and attenuates anti-PEG IgM production: An alternative to PEGylation (2022 · Nanomedicine Nanotechnology Biology and Medicine · 被引 18)
• Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors (2022 · Frontiers in Immunology · 被引 18)
• Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter study (2025 · EBioMedicine · 被引 16)
• Design, Synthesis, and Biological Evaluation of Lysine-Stapled Peptide Inhibitors of p53-MDM2/MDMX Interactions with Potent Antitumor Activity In Vivo (2024 · Journal of Medicinal Chemistry · 被引 12)
• Corrigendum: GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT–Mediated EMT (2022 · Frontiers in Cell and Developmental Biology · 被引 12)